The role of epigenetics in age-related macular degeneration

被引:46
|
作者
Gemenetzi, M. [1 ]
Lotery, A. J. [1 ,2 ]
机构
[1] Univ Southampton, Southampton Eye Unit, Southampton, Hants, England
[2] Univ Southampton, Southampton Univ Hosp, Fac Med, Southampton, Hants, England
关键词
PIGMENT EPITHELIAL-CELLS; DNA METHYLATION; GENE-EXPRESSION; NADPH OXIDASE; UP-REGULATION; CHROMATIN-STRUCTURE; ALZHEIMERS-DISEASE; BRUCHS MEMBRANE; RISK-FACTORS; HYPOXIA;
D O I
10.1038/eye.2014.225
中图分类号
R77 [眼科学];
学科分类号
100212 ;
摘要
It is becoming increasingly evident that epigenetic mechanisms influence gene expression and can explain how interactions between genetics and the environment result in particular phenotypes during development. The extent to which this epigenetic effect contributes to phenotype heritability in age-related macular degeneration (AMD) is currently ill defined. However, emerging evidence suggests that epigenetic changes are relevant to AMD and as such provide an exciting new avenue of research for AMD. This review addresses information on the impact of posttranslational modification of the genome on the pathogenesis of AMD, such as DNA methylation changes affecting antioxidant gene expression, hypoxia-regulated alterations in chromatin structure, and histone acetylation status in relation to angiogenesis and inflammation. It also contains information on the role of non-coding RNA-mediated gene regulation in AMD at a posttranscriptional (before translation) level. Our aim was to review the epigenetic mechanisms that cause heritable changes in gene activity without changing the DNA sequence. We also describe some long-term alterations in the transcriptional potential of a cell, which are not necessarily heritable but remains to be defined in the future. Increasing understanding of the significance of common and rare genetic variants and their relationship to epigenetics and environmental influences may help in establishing methods to assess the risk of AMD. This in turn may allow new therapeutic interventions for the leading cause of central vision impairment in patients over the age of 50 years in developed countries. Search strategy We searched the MEDLINE/PubMed database following MeSH suggestions for articles including the terms: 'ocular epigenetic mechanisms', 'human disease epigenetics', and 'age-related macular degeneration genetics'. The headline used to locate related articles in PubMed was 'epigenetics in ocular disease', and to restrict search, we used the headlines 'DNA methylation in age related macular degeneration', 'altered gene expression in AMD pathogenesis'. A manual search was also based on references from these articles as well as review articles.
引用
收藏
页码:1407 / 1417
页数:11
相关论文
共 50 条
  • [31] AGE-RELATED MACULAR DEGENERATION
    BRESSLER, NM
    BRESSLER, SB
    FINE, SL
    SURVEY OF OPHTHALMOLOGY, 1988, 32 (06) : 375 - 413
  • [32] Age-related macular degeneration
    Coleman, Hanna R.
    Chan, Chi-Chao
    Ferris, Frederick L., III
    Chew, Emily Y.
    LANCET, 2008, 372 (9652): : 1835 - 1845
  • [33] Age-related macular degeneration
    Elfervig, LS
    NURSE PRACTITIONER FORUM-CURRENT TOPICS AND COMMUNICATIONS, 1998, 9 (01): : 4 - 6
  • [34] Age-related macular degeneration
    Ayoub, Tariq
    Patel, Nishal
    JOURNAL OF THE ROYAL SOCIETY OF MEDICINE, 2009, 102 (02) : 56 - 61
  • [36] AGE-RELATED MACULAR DEGENERATION
    CAPINO, DG
    LEIBOWITZ, HM
    HOSPITAL PRACTICE, 1988, 23 (3A): : 23 - &
  • [37] Age-Related Macular Degeneration
    Panesar, Kiran
    US PHARMACIST, 2015, 40 (06) : 22 - 26
  • [38] Age-related Macular Degeneration
    Wang, Wei
    Dean, Douglas C.
    Kaplan, Henry J.
    DISCOVERY MEDICINE, 2010, 9 (44) : 13 - 15
  • [39] Age-Related Macular Degeneration
    Cheung, Lily K.
    Eaton, Angie
    PHARMACOTHERAPY, 2013, 33 (08): : 838 - 855
  • [40] Age-related macular degeneration
    Soubrane, G.
    JOURNAL FRANCAIS D OPHTALMOLOGIE, 2007, 30 : S3 - S4